113. Muscular dystrophy Clinical trials / Disease details

Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03779646 (ClinicalTrials.gov)	January 16, 2019	14/12/2018	Bisoprolol in DMD Early Cardiomyopathy	Bisoprolol for Early Cardiomyopathy in Duchenne Muscular Dystrophy: a Randomized, Controlled Trial	Duchenne Muscular Dystrophy;Cardiomyopathy, Dilated	Drug: Bisoprolol Fumarate	Peking Union Medical College Hospital	National Natural Science Foundation of China;Chinese Academy of Medical Sciences	Recruiting	7 Years	N/A	Male	42	Phase 2/Phase 3	China
2	EUCTR2007-005932-10-GB (EUCTR)	30/03/2009	14/04/2009	A double-blind randomised multi-centre, placebo-controlled trial of combined ACE-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males with DMD without echo-detectable left ventricular dysfunction - DMD-Heart Protection	A double-blind randomised multi-centre, placebo-controlled trial of combined ACE-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males with DMD without echo-detectable left ventricular dysfunction - DMD-Heart Protection	Duchenne muscular dystrophy MedDRA version: 9.1;Level: LLT;Classification code 10013801;Term: Duchenne muscular dystrophy	Trade Name: Perindopril 2mg Tablets Product Name: Perindopril Trade Name: Cardicor (Merck brand) Product Name: Bisoprolol	Newcastle upon Tyne Hospitals NHS Foundation Trust	NULL	Not Recruiting			Female: no Male: yes	140	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no	United Kingdom